title: MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients.
abstract: OBJECTIVE
  The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in three patients using gadoxetic acid, a newly developed liver-specific MR contrast agent.
  
  
  CONCLUSIONS
  In all three patients, more than 100 liver adenomas revealed no metabolism of the new liver-specific contrast agent in the delayed phase. Because of absent or strongly reduced intracellular uptake of gadoxetic acid in all adenomas during delayed contrast-enhanced series, differentiation of adenomas from dysplastic or malignant lesions was not possible.
authors.affiliation: Department of Radiology, University Hospital Basel, Basel, Switzerland. olivier.giovanoli@ksa.ch
authors.forename: Olivier
authors.initials: O
authors.lastname: Giovanoli
authors.forename: Markus
authors.initials: M
authors.lastname: Heim
authors.forename: Luigi
authors.initials: L
authors.lastname: Terracciano
authors.forename: Georg
authors.initials: G
authors.lastname: Bongartz
authors.forename: Hans P
authors.initials: HP
authors.lastname: Ledermann
mesh_terms: D000236:Adenoma / Q000473:pathology*; D000328:Adult; D003287:Contrast Media; D005260:Female; D019786:Gadolinium DTPA; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged
chemical_list: D003287:Contrast Media; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA